NCT00823524
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +101 more
- Locations
-
- University of Ulsan, Asan Medical Center Seoul, South Korea
Clinical trial condition
Lymphoma, Extranodal NK-T-Cell
Explore clinical trials studying Lymphoma, Extranodal NK-T-Cell. Study availability and eligibility vary by location and protocol.
157 public trials
17 recruiting studies
Lymphoma, Extranodal NK-T-Cell trial results
NCT00962507
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +49 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- City of Hope Medical Group Pasadena, California, United States
Completed
Gemcitabine in NK/T Cell Lymphoma
NCT01660568
- Conditions
- Lymphoma, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Non-Hodgkin, +4 more
- Locations
-
- Samsung Medical Center Seoul, South Korea
NCT00891072
- Conditions
- Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Blood Protein Disorders, +121 more
- Locations
-
- Cancer Institute of New Jersey New Brunswick, New Jersey, United States
NCT00787761
- Conditions
- Adenocarcinoma, Blast Crisis, Blood Protein Disorders, +82 more
- Locations
-
- Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
NCT00666211
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +108 more
- Locations
-
- Jennie Stuart Medical Center Hopkinsville, Kentucky, United States
- Mitchell Memorial Cancer Center at Owensboro Medical Health System Owensboro, Kentucky, United States
- Erlanger Health System Chattanooga, Tennessee, United States
- Tennessee Plateau Oncology Crossville, Tennessee, United States
NCT01341119
- Conditions
- Extranodal NK/T Cell Lymphoma, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +4 more
- Locations
-
- Samsung Medical Center Seoul, South Korea
NCT00237627
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +99 more
- Locations
-
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
NCT00734890
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +67 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
Completed
Fenretinide Lym-X-Sorb™ in Treating Patients With Recurrent or Resistant Solid Tumors or Lymphoma
NCT00589381
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +48 more
- Locations
-
- Childrens Hospital Los Angeles Los Angeles, California, United States
- USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
- Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital Fort Lauderdale, Florida, United States
- Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States